These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 30458722)

  • 1. Driving following defibrillator implantation: development and pilot results from a nationwide questionnaire.
    Bjerre J; Rosenkranz SH; Christensen AM; Schou M; Jøns C; Gislason G; Ruwald AC
    BMC Cardiovasc Disord; 2018 Nov; 18(1):212. PubMed ID: 30458722
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Driving Restrictions and Early Arrhythmias in Patients Receiving a Primary-Prevention Implantable Cardioverter-Defibrillator (DREAM-ICD) Study.
    Steinberg C; Cheung CC; Wan D; Sodhi A; Claros S; Staples JA; Philippon F; Laksman Z; Sarrazin JF; Bennett M; Plourde B; Deyell MW; Andrade JG; Roy K; Yeung-Lai-Wah JA; Molin F; Hawkins NM; Blier L; Nault I; O'Hara G; Krahn AD; Champagne J; Chakrabarti S
    Can J Cardiol; 2020 Aug; 36(8):1269-1277. PubMed ID: 32474110
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Time Course of Subsequent Shocks After Initial Implantable Cardioverter-Defibrillator Discharge and Implications for Driving Restrictions.
    Merchant FM; Hoskins MH; Benser ME; Roberts G; Bastek AN; Knezevic A; Huang Y; Langberg JJ; Leon AR; El-Chami MF
    JAMA Cardiol; 2016 May; 1(2):181-8. PubMed ID: 27437889
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Psychometric properties of HeartQoL, a core heart disease-specific health-related quality of life questionnaire, in Danish implantable cardioverter defibrillator recipients.
    Zangger G; Zwisler AD; Kikkenborg Berg S; Kristensen MS; Grønset CN; Uddin J; Pedersen SS; Oldridge NB; Thygesen LC
    Eur J Prev Cardiol; 2018 Jan; 25(2):142-149. PubMed ID: 28952795
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical effect of implantable cardioverter defibrillator replacements: when should you resume driving after an implantable cardioverter defibrillator replacement?
    Kawata H; Noda T; Kurita T; Yamagata K; Yamada Y; Okamura H; Satomi K; Shimizu W; Suyama K; Aihara N; Isobe M; Kamakura S
    Circ J; 2010 Nov; 74(11):2301-7. PubMed ID: 20877125
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quality of life and driving in recipients of the implantable cardioverter-defibrillator.
    Jung W; Lüderitz B
    Am J Cardiol; 1996 Sep; 78(5A):51-6. PubMed ID: 8820836
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effectiveness of a comprehensive interactive eHealth intervention on patient-reported and clinical outcomes in patients with an implantable cardioverter defibrillator [ACQUIRE-ICD trial]: study protocol of a national Danish randomised controlled trial.
    Pedersen SS; Skovbakke SJ; Wiil UK; Schmidt T; dePont Christensen R; Brandt CJ; Sørensen J; Vinther M; Larroudé CE; Melchior TM; Riahi S; Smolderen KGE; Spertus JA; Johansen JB; Nielsen JC
    BMC Cardiovasc Disord; 2018 Jul; 18(1):136. PubMed ID: 29969990
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Driving restrictions after implantable cardioverter defibrillator implantation: an evidence-based approach.
    Thijssen J; Borleffs CJ; van Rees JB; de Bie MK; van der Velde ET; van Erven L; Bax JJ; Cannegieter SC; Schalij MJ
    Eur Heart J; 2011 Nov; 32(21):2678-87. PubMed ID: 21646229
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Driving following defibrillator implantation: a nationwide register-linked survey study.
    Bjerre J; Rosenkranz SH; Schou M; Jøns C; Philbert BT; Larroudé C; Nielsen JC; Johansen JB; Riahi S; Melchior TM; Torp-Pedersen C; Hlatky M; Gislason G; Ruwald AC
    Eur Heart J; 2021 Sep; 42(35):3529-3537. PubMed ID: 33954626
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Driving Restrictions Following Defibrillator Implantation: A Nationwide Register-linked Survey Study on the Impact on Employment, Daily Living, and Driving Behaviour.
    Hansen MH; Rasmussen TB; Risom SS; Rosenkranz S; Schou M; Larroudé C; Gislason G; Ruwald AC; Bjerre J
    Eur Heart J Qual Care Clin Outcomes; 2024 Aug; ():. PubMed ID: 39122660
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peri-procedural routines, implantation techniques, and procedure-related complications in patients undergoing implantation of subcutaneous or transvenous automatic cardioverter-defibrillators: results of the European Snapshot Survey on S-ICD Implantation (ESSS-SICDI).
    Lenarczyk R; Boveda S; Haugaa KH; Potpara TS; Syska P; Jedrzejczyk-Patej E; Chauvin M; Sadoul N; Dagres N
    Europace; 2018 Jul; 20(7):1218-1224. PubMed ID: 29762683
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Driving restrictions for arrhythmia patients--with special reference to the implantable cardioverter/defibrillator].
    Lüderitz B; Jung W
    Z Kardiol; 1996; 85 Suppl 6():115-21. PubMed ID: 9064955
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Experiences of driving and driving restrictions in recipients with an implantable cardioverter defibrillator--the patient perspective.
    Johansson I; Strömberg A
    J Cardiovasc Nurs; 2010; 25(6):E1-E10. PubMed ID: 20938245
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association between socioeconomic factors and ICD implantation in a publicly financed health care system: a Danish nationwide study.
    Winther-Jensen M; Hassager C; Lassen JF; Køber L; Torp-Pedersen C; Hansen SM; Lippert F; Christensen EF; Kragholm K; Kjaergaard J
    Europace; 2018 Jul; 20(7):1129-1137. PubMed ID: 29016817
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The use of guideline recommended beta-blocker therapy in primary prevention implantable cardioverter defibrillator patients: insight from Danish nationwide registers.
    Ruwald AC; Gislason GH; Vinther M; Johansen JB; Nielsen JC; Petersen HH; Torp-Pedersen C; Riahi S; Jøns C
    Europace; 2018 Feb; 20(2):301-307. PubMed ID: 28339659
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characteristics and outcomes of diabetic patients with an implantable cardioverter defibrillator in a real world setting: results from the Israeli ICD registry.
    Steiner H; Geist M; Goldenberg I; Suleiman M; Glikson M; Tenenbaum A; Swissa M; Fisman EZ; Golovchiner G; Strasberg B; Barsheshet A;
    Cardiovasc Diabetol; 2016 Dec; 15(1):160. PubMed ID: 27905927
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sex differences in implantable cardioverter-defibrillator implantation indications and outcomes: lessons from the Nationwide Israeli-ICD Registry.
    Amit G; Suleiman M; Konstantino Y; Luria D; Kazatsker M; Chetboun I; Haim M; Gavrielov-Yusim N; Goldenberg I; Glikson M;
    Europace; 2014 Aug; 16(8):1175-80. PubMed ID: 24554524
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Living with hypertrophic cardiomyopathy and an implantable defibrillator.
    Magnusson P; Jonsson J; Mörner S; Fredriksson L
    BMC Cardiovasc Disord; 2017 May; 17(1):121. PubMed ID: 28490380
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phantom shocks in patients with implantable cardioverter defibrillator: results from a randomized rehabilitation trial (COPE-ICD).
    Berg SK; Moons P; Zwisler AD; Winkel P; Pedersen BD; Pedersen PU; Svendsen JH
    Europace; 2013 Oct; 15(10):1463-7. PubMed ID: 23599170
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Driving and implantable cardioverter-defibrillator shocks for ventricular arrhythmias: results from the TOVA study.
    Albert CM; Rosenthal L; Calkins H; Steinberg JS; Ruskin JN; Wang P; Muller JE; Mittleman MA;
    J Am Coll Cardiol; 2007 Dec; 50(23):2233-40. PubMed ID: 18061071
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.